RCS - Cambridge Cognition - Investor Webinar and Analyst Briefing

Cambridge Cognition HoldingsAnnouncement

26/04/2023 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230426:nRSZ4481Xa&default-theme=true

RNS Number : 4481X  Cambridge Cognition Holdings PLC  26 April 2023

REACH

Cambridge Cognition Holdings Plc

 

("Cambridge Cognition" or the "Company")

 

Investor Webinar and Analyst Briefing

 

Cambridge Cognition (AIM: COG), which develops and markets digital solutions
to assess brain health, will be announcing the Company's preliminary financial
results for the year ended 31 December 2022 on Wednesday 3 May 2023 and is
pleased to provide details of an investor webinar and analyst briefing being
held on that day.

Investor Webinar

Cambridge Cognition's management will be hosting an online presentation and
Q&A session at 5.30 p.m. BST on Wednesday 3 May 2023. This session is open
to all existing and prospective shareholders. Those wishing to attend should
email cog@investor-focus.co.uk (mailto:cog@investor-focus.co.uk)  and they
will be provided with log in details.

Participants will have the opportunity to submit questions during the session,
but questions are welcomed in advance and may be submitted to:
cog@investor-focus.co.uk (mailto:cog@investor-focus.co.uk)  .

Analyst Briefing

The Company's management will be hosting a presentation for analysts on the
day of results at 9:30 a.m. BST, those who wish to attend the briefing should
register their interest with Zach Cohen at zach.cohen@investor-focus.co.uk
(mailto:zach.cohen@investor-focus.co.uk) or on 020 3934 6637.

Enquiries

 

 Cambridge Cognition Holdings Plc                      Tel: 012 2381 0700

 Matthew Stork, Chief Executive Officer                press@camcog.com (mailto:press@camcog.com)

 Stephen Symonds, Chief Financial Officer

 Panmure Gordon (UK) Limited (NOMAD and Joint Broker)  Tel: 020 7886 2500

 Freddy Crossley / Emma Earl                           (Corporate Finance)

 Rupert Dearden                                        (Corporate Broking)

 Dowgate Capital Limited (Joint Broker)                Tel: 020 3903 7715

 David Poutney / James Serjeant                         

 IFC Advisory Ltd (Financial PR and IR)                Tel: 020 3934 6630

 Tim Metcalfe / Graham Herring / Zach Cohen             cog@investor-focus.co.uk

 

 

About Cambridge Cognition

 

Cambridge Cognition is a technology company developing digital health products
to better understand, detect and treat conditions affecting brain health. The
Company's software products assess cognitive health in patients worldwide to
improve clinical trial outcomes, identify and stratify patients early and
improve global efficiency in pharmaceutical and healthcare industries.

For further information visit www.cambridgecognition.com
(http://www.cambridgecognition.com)

 

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NRABIGDSRSDDGXU